The Global Preimplantation Genetic Diagnosis Market is expected to reach USD 541.8 million in 2022



 Before implantation, preimplantation genetic testing is undertaken to aid in the detection of genetic abnormalities in the embryos. Preimplantation genetic testing examines the genetic profile of embryos, allowing for selective pregnancy termination to be avoided. Before transferring an IVF embryo to the uterus, a cell from the embryo that will be examined is extracted. The extracted cell is examined for a genetic disorder (for instance, cystic fibrosis).

Technological improvements in the field of genetic analysis and the increased risk of chromosomal abnormalities with rising maternal age are driving market expansion. In addition, factors such as male and female infertility are fueling market expansion. However, the market's growth is hampered by high costs connected with preimplantation genetic testing and adverse regulatory regulations. Growing medical tourism and increased awareness of preimplantation genetic testing would provide the profitable potential for market growth.

The global Preimplantation Genetic Diagnosis Market is expected to grow at a CAGR of 10.0 percent from USD 336.4 million in 2017 to USD 541.8 million in 2022. The rising rate of infertility around the world, the growing number of fertility clinics around the world, public-private investments in the field of preimplantation genetic testing, technological advancements in the field of genetic analysis, and the high risk of chromosomal abnormalities in the fetus with increasing maternal age are all driving this market forward.

The market is divided into two categories based on products: reagents and consumables and instruments. The market is divided into two types of procedures: preimplantation genetic screening and preimplantation genetic diagnosis. The market is divided into five categories based on technology: next-generation sequencing, polymerase chain reaction, fluorescence in situ hybridization, comparative genomic hybridization, and single-nucleotide polymerase chain reaction. Aneuploidy, single-gene disorders, structural chromosomal abnormalities, X-linked disorders, human leukocyte typing, and gender identification are some of the applications that the market can be divided into. It has been divided into four regions: North America, Europe, Asia-Pacific, and LAMEA.

Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technologies Inc., PerkinElmer Inc., Coopersurgical, Inc., Abbott Laboratories, Natera, Inc., Oxford Gene Technology, Yukon Genomics and SciGene Corporation are among the market's major companies.

Comments

Post a Comment

Popular posts from this blog

Quaternary Ammonium Compounds Market to Grow at USD 1.63 billion by 2027: COVID Impact & Post COVID Analysis, Business Opportunities, and Strategies

Image
  By 2027, the global market for Quats (Quaternary Ammonium Compounds) is expected to reach USD 1.63 billion. The market is being driven by the rise in the occurrence of hospital-acquired infections (HAIs) and the implementation of stringent regulations and favorable government initiatives on disinfection and sterilization. Developing economies are expected to give significant opportunities for growth. Fabric softeners, disinfectants, surfactants, antistatic agents, and wood preservation are just a few of the uses for quaternary ammonium compounds. The product's numerous applications are projected to raise demand shortly. Quaternary ammonium compounds are commonly employed as conditioning agents in personal care products, such as skin, textile, and hair softeners. The surfactant industry considers QACs to be the ultimate workhorse. They're on the USEPA's "High Production Volume Chemicals" list. Self-assembly, surface-active properties, detergency, and antibact...
Read more

Butyraldehyde Market Trends, Growth, Demand, opportunities, Scope & Forecast 2027 by CMI

Image
  Buthylaldehyde (also known as butanal) is a 4-carbon aldehyde that is used as a building block in organic syntheses to make various products such as n-butanol, 2-ethyl hexanol, 2-ethyl hexanoic acid, trimethylolpropane, and polyvinyl butyral. Pharmaceuticals, agrochemicals, antioxidants, textile auxiliaries, perfumes, flavors, and many forms of additives are all made with it as an intermediate (fillers, wetting agents, defoaming agents, improvers). Alcohols (mono- and multi-hydroxide), acids, amines, and esters are all made from N-butyraldehyde as a raw material. Rubber accelerators, synthetic resins, plasticizers, solvents, and high molecular weight polymers are the biggest uses of butyraldehyde. All of these buthylaldehyde applications are detailed in this study. Butyraldehyde is widely used as a starting material for the downstream organic synthesis of n-butanol, trimethylolpropane, 2-ethyl hexanoic acid, and polyvinyl butyral. Pharmaceutical intermediates, synthetic resins,...
Read more

Glass Mat Thermoplastic Market : Size, Growth, Regional Analysis, And Market Area

Image
Glass mat thermoplastic is a thermoplastic that can be easily moulded and is used to make a variety of components, primarily in the automotive industry. Because of the longer residual length of the glass strands, glass mat thermoplastic has better mechanical properties than injection moulded reinforced thermoplastic. It is primarily used as a replacement for steel and aluminium. They are available in panel form as well as 3D structural component form. Furthermore, they are a lightweight material with a low relative density, excellent hardness and rigidity at low temperatures, and are chemical and moisture resistant . These are durable materials with ease of recyclability. Furthermore, the demand for the glass mat thermoplastic material from the automobile and aeration industries leads to market growth. When compared to other end-use industries, the automotive application segment is expected to remain the largest. Furthermore, a surge in government initiatives for increased fuel eco...
Read more